Table 1 Patients' characteristics and... | American Society of Hematology

Table 1

Patients' characteristics and CBL family, TET2, ASXL1, and IDH family mutations (N = 54)

Phase	WHO diagnosis	Cases with variants
Phase	WHO diagnosis	CBL family	TET2	ASXL1	IDH family
Aggressive	AP (N = 14)	1	2	0	0
	BP (myeloid) (N = 20)	2	4	2	2
	BP (nonmyeloid) (N = 6)	0	0	0	0
Chronic	CP (N = 14)	0	0	0	0

Phase	WHO diagnosis	Cases with variants
Phase	WHO diagnosis	CBL family	TET2	ASXL1	IDH family
Aggressive	AP (N = 14)	1	2	0	0
	BP (myeloid) (N = 20)	2	4	2	2
	BP (nonmyeloid) (N = 6)	0	0	0	0
Chronic	CP (N = 14)	0	0	0	0

WHO indicates World Health Organization; AP, accelerated phase; BP, blast phase; and CP, chronic phase.